Susquehanna International Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-238,914
Closed -$10.3M 10501
2015
Q3
$10.3M Buy
238,914
+87,252
+58% +$3.68M ﹤0.01% 1791
2015
Q2
$6.41M Buy
151,662
+138,295
+1,035% +$5.83M ﹤0.01% 2555
2015
Q1
$518K Buy
+13,367
New +$515K ﹤0.01% 7042
2014
Q3
Sell
-8,619
Closed -$295K 10433
2014
Q2
$283K Sell
8,619
-36,532
-81% -$1.25M ﹤0.01% 8488
2014
Q1
$1.66M Buy
45,151
+26,485
+142% +$972K ﹤0.01% 4637
2013
Q4
$716K Buy
+18,666
New +$589K ﹤0.01% 6098

Other funds holding WX

Susquehanna International Group's WX Position: Q4 2015 in Review

Susquehanna International Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 238,914 shares — an estimated $10.3M sold.

Susquehanna International Group first reported a position in WX in Q4 2013 and held it in 6 quarters. The position peaked at $10.3M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Susquehanna International Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Susquehanna International Group sold 238,914 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $10.3M.
  • Susquehanna International Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $10.3M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.